The exact treatment for PE depends on its severity and whether you need critical treatment in an emergency room setting. PE medications are usually considered before medical procedures.

The trial adds much-needed randomized data to an area where it’s been lacking. Questions about methods muddy interpretation.

(Nasdaq:NARI) today announced positive results from its prospective PEERLESS trial for the FlowTriever system.

KKR's acquisition of SunFireMatrix and Consello's purchase of EHE Health are among the deals that exemplify the new trends.

Penumbra (NYSE:PEN) today announced new data demonstrating improved outcomes with its computer-assisted vacuum thrombectomy ...

Thrombolex announced findings from the RESCUE-II trial, which is evaluating the company’s Bashir endovascular catheter to ...

Primary endpoint win driven by both hard clinical outcomes and hospital resource utilizationIRVINE, Calif., Oct. 29, 2024 ...

A nationwide retrospective study evaluated health care resource utilization and outcomes among patients with ...

Penumbra (PEN) announced new data that demonstrate patients with intermediate-risk pulmonary embolism – PE – treated with ...

Mandy Stewart, wife of defensive coordinator and longtime PE coach Perry Stewart ... is something that has been missed by the ...

The Bristol Centre for Reproductive Medicine (BCRM) has been bought by private equity backed peer FutureLife Group. BCRM, trading as Fertility Bristol, is a fertility c ...